Cargando…

Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases

Detalles Bibliográficos
Autores principales: Ho, Bo Man, Du, Lin, Chu, Wai Kit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676217/
https://www.ncbi.nlm.nih.gov/pubmed/36403422
http://dx.doi.org/10.1016/j.ebiom.2022.104368
_version_ 1784833542886260736
author Ho, Bo Man
Du, Lin
Chu, Wai Kit
author_facet Ho, Bo Man
Du, Lin
Chu, Wai Kit
author_sort Ho, Bo Man
collection PubMed
description
format Online
Article
Text
id pubmed-9676217
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96762172022-11-22 Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases Ho, Bo Man Du, Lin Chu, Wai Kit eBioMedicine Comment Elsevier 2022-11-17 /pmc/articles/PMC9676217/ /pubmed/36403422 http://dx.doi.org/10.1016/j.ebiom.2022.104368 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Comment
Ho, Bo Man
Du, Lin
Chu, Wai Kit
Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases
title Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases
title_full Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases
title_fullStr Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases
title_full_unstemmed Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases
title_short Novel epigenetic therapy for Th17 cell mediated autoimmune inflammatory diseases
title_sort novel epigenetic therapy for th17 cell mediated autoimmune inflammatory diseases
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676217/
https://www.ncbi.nlm.nih.gov/pubmed/36403422
http://dx.doi.org/10.1016/j.ebiom.2022.104368
work_keys_str_mv AT hoboman novelepigenetictherapyforth17cellmediatedautoimmuneinflammatorydiseases
AT dulin novelepigenetictherapyforth17cellmediatedautoimmuneinflammatorydiseases
AT chuwaikit novelepigenetictherapyforth17cellmediatedautoimmuneinflammatorydiseases